Fig. 1
From: LINC02159 promotes non-small cell lung cancer progression via ALYREF/YAP1 signaling
LINC02159 is significantly upregulated in NSCLC and associated with poor prognosis. A Cluster analysis of differential lncRNA expression in 3 pairs of NSCLC tissues and adjacent non-tumor tissues. B Volcano map of differential lncRNA expression. C Top ten lncRNAs with significant upregulation. D qRT-PCR analyses of LINC02159 expression in different lung cancer cell lines. E RNA nuclear/cytosol fractionation experiment. F FISH experiment for the subcellular distribution of LINC02159 in NSCLC cells. G qRT-PCR analyses of LINC02159 expression in 50 pairs of NSCLC tissues and adjacent non-tumor tissues. H qRT-PCR analysis of LINC02159 expression in the serum of NSCLC patients, pneumonia patients and healthy controls. I ROC curves among NSCLC patients, healthy controls, and pneumonia patients. J TCGA database analysis of LINC02159 expression in tumor and normal tissues of NSCLC patients. (***P < 0.001)